1149 related articles for article (PubMed ID: 29268722)
1. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
2. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
[TBL] [Abstract][Full Text] [Related]
4. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
[TBL] [Abstract][Full Text] [Related]
7. Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.
Park HJ; Jang HY; Kim SY; Lee SJ; Won HJ; Byun JH; Choi SH; Lee SS; An J; Lim YS
J Hepatol; 2020 Apr; 72(4):718-724. PubMed ID: 31836549
[TBL] [Abstract][Full Text] [Related]
8. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.
Demirtas CO; Gunduz F; Tuney D; Baltacioglu F; Kani HT; Bugdayci O; Alahdab YO; Ozdogan OC
Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):517-523. PubMed ID: 31524775
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis.
Kim HL; An J; Park JA; Park SH; Lim YS; Lee EK
Hepatology; 2019 Apr; 69(4):1599-1613. PubMed ID: 30365164
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
[No Abstract] [Full Text] [Related]
11. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
13. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
14. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
[TBL] [Abstract][Full Text] [Related]
15. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
Yu NC; Chaudhari V; Raman SS; Lassman C; Tong MJ; Busuttil RW; Lu DS
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):161-7. PubMed ID: 20920597
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
Zoli M; Magalotti D; Bianchi G; Gueli C; Marchesini G; Pisi E
Cancer; 1996 Sep; 78(5):977-85. PubMed ID: 8780534
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma surveillance: An evidence-based approach.
Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
20. [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].
Jiang YY; Wang XY; Guo XM; Jiang XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):767-72. PubMed ID: 21170112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
